Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction

Published:2017-04 Issue:4 Volume:5 Page:241-252
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Anand Inder S.,Claggett Brian,Liu Jiankang,Shah Amil M.,Rector Thomas S.,Shah Sanjiv J.,Desai Akshay S.,O’Meara Eileen,Fleg Jerome L.,Pfeffer Marc A.,Pitt Bertram,Solomon Scott D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Prognosis in heart failure with a normal ejection fraction;Cleland;N Engl J Med,2007

2. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial;Anand;Circ Heart Fail,2011

3. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study;Teerlink;Lancet,2009

4. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

5. Irbesartan in patients with heart failure and preserved ejection fraction;Massie;N Engl J Med,2008

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Update in Heart Failure with Preserved Ejection Fraction;Current Heart Failure Reports;2024-09-03

2. Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier;Journal of Clinical Medicine;2024-08-07

3. Response by Chatur et al to Letter Regarding Article, “Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial”;Circulation;2024-08-06

4. Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy;Circulation Research;2024-08-02

5. Semaglutide and NT-proBNP in Obesity-Related HFpEF;Journal of the American College of Cardiology;2024-07